SMURF2 and invasive carcinoma: In samples with invasive carcinomas, Smurf2 staining was found decreased focally or sometimes diffusely, and the downregulation of Smuf2 was significantly more obvious in TNBCs compared to ER+/PR + cancers (Figure 1A lower panels, Figure 1B).